The Colon Cancer Alliance is thrilled to announce the addition of two new members to the Board of Directors, David Schoeman, Senior Partner in the New York Office of McKinsey & Company, and Lee Dranikoff, Managing Director at American Studies. Both members have a personal understanding of colorectal cancer and its impact, which deepens their commitment to helping others affected and to one day finding a cure.
“It is with great enthusiasm that we welcome our newest board members. Both David and Lee embody the essence of leadership and bring strong direction and positive energy to the table,” Michael Sapienza, CEO.
Lee Dranikoff, JD – Lee joined American Securities in 2003. He manages the overall deployment of the functional experts within the Resources Group and directly leads the in-house Strategy Team in the U.S. In this capacity, Lee directs the Resources Group support of due diligence on prospective investments, as well as the extensive Shared Vision process that is used at all portfolio companies. Prior to McKinsey, Lee worked as an attorney at Weil, Gotshal & Manges. Lee received a BA and an MA in Economics from Johns Hopkins University and a JD from Harvard Law School.
David Schoeman, MBA – David is a Senior Partner in the New York Office of McKinsey & Company where he servers Private Equity firms and their portfolio companies, Banks and Insurance carriers. Prior to joining McKinsey, David was a systems developer at Morgan Stanley supporting the Prime Brokerage, Clearing, and Custody businesses David received an MBA from Columbia Business School and BA in Economics and History from Northwestern University. He is a published writer on bank economics and school finance reform.
“The Colon Cancer Alliance is working tirelessly to extend its reach into the colorectal cancer community. By engaging new board leaders to uphold and encompass our mission, we are on the best path forward with the addition of Lee Dranikoff and David Shoeman,” Michael Sapienza, CEO.
About the Colon Cancer Alliance
The Colon Cancer Alliance is a national nonprofit committed to ending colon cancer within our lifetime. Working with our nation of passionate advocates, we are empowered to support the needs of patients and survivors, eager to raise awareness of preventative screening, and poised to help fund critical research. To learn more visit https://www.ccalliance.org/